Preview
The PRIMAvera pivotal clinical trial of Science Corporation's PRIMA retinal BCI implant in 38 patients with geographic atrophy (advanced dry AMD) — the study whose results were published in NEJM October 2025 showing 80% of patients restored functional…
The complete summary, “why it matters” analysis and the original source link are available to members.
BCICE MarkPhase 3Pivotal Trial